In March this year, NovaDel announced its plans to sell all assets with the intention of liquidating the company and distributing its remaining cash to shareholders. With the
Under the deal, Merck will acquire all of Sigma-Aldrich for $140 a share in cash, a 37% premium to Sigma’s latest closing price of $102.37. The acquisition is
Pathologic myopia and the associated myopic CNV is the second most common cause of blindness, in this country. Eylea approval is based on positive data from the Phase
ALPHANATE is used to control and prevent bleeding in patients with Hemophilia A as well as for surgical and/or invasive procedures in adult and pediatric patients with von
The company is focused on the development of new medications to help patients with cognitive disorders, including ADHD and Fragile X Syndrome. The 300-patient, randomized, placebo-controlled trial was
The contract is aimed at advancing development of the company’s thermostabilization technology, ThermoVax, combined with its ricin toxin vaccine, Rivax, as a medical countermeasure (MCM) to prevent the
Biotec is a provider of clinical trials and temperature controlled pharmaceutical services. The company said that the acquisition will help in expanding its presence in the UK/EU region
Zydelig is an oral inhibitor of phosphoinositide 3-kinase (PI3K) delta, which plays a major role in the activation, proliferation and viability of B cells, a critical component of
The trial called DURATION-NEO-1 compared an investigational formulation of exenatide once-weekly suspension for autoinjection with twice-daily exenatide (Byetta) injection in these patients who had inadequate glycaemic control. About
GSK China Investment (GSKCI) offered money or property to non-government personnel in order to obtain improper commercial gains, and been found guilty of bribing non-government personnel. The company
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.